Forecasting Analytics

For life sciences companies evaluating pipeline assets, identifying candidates is only half the problem. The harder constraint is building a credible commercial forecast for each shortlisted asset, fast enough to act on it. A traditional single forecast takes three to six weeks. When a business development (BD) team is weighing multiple candidates against a conference deadline or a competing bidder, that timeline decides whether a deal gets made.

Axtria's Early Pipeline Decision Engine compresses that process from weeks to days for any indication, rare or well-characterized, without rebuilding the approach for each new asset. A disease-agnostic landscape analytics dashboard, agentic literature search, real-world evidence tools, and a configurable forecasting model work together in one interconnected platform, so the commercial rigor that executive and board review demands is available at the pace that deal timelines require.